These findings highlight the importance of targeting PD-1+ T cells in achieving a strong anti-tumor response and underline the therapeutic potential of AWT020 in providing a favorable safety profile while greatly enhancing anti-tumor efficacy. This evidence concerns the gene PDCD1 and neoplasm.